Huize Pharmaceutical

Hunan Huize Pharmaceutical Technology is a specialized Contract Research Organization (CRO) based in China, focusing on clinical pharmacology and early-stage clinical development. Established in 2014, the company provides a full suite of services including bioequivalence (BE) studies, Phase I-IV clinical trials, and pharmacokinetics/pharmacodynamics (PK/PD) analysis. Huize is particularly noted for its all-in-one clinical pharmacology platform which integrates trial design, site management, and bioanalysis. With headquarters in Changsha and multiple clinical centers, the firm supports pharmaceutical companies in accelerating drug registration and market entry through high-quality, GXP-compliant research.